Skip to main content
Watch Insiders
Market intelligence
OTLCSector not reported

Oncotelic Therapeutics, Inc. insider activity

In the last 90 days, 2 corporate insiders purchased $27,483 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
2
90-day purchase value
$27,483
Corporate buyers
2
Latest transaction
Jun 22, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 22, 2026Vuong TrieuCHAIRMAN AND CEOOpen Market Purchase255,000$0.05$11,475
Jun 22, 2026Amit B. ShahCFOOpen Market Purchase20,000$0.05$1,000
Jun 15, 2026Vuong TrieuCHAIRMAN AND CEOOpen Market Purchase335,759$0.04$15,008